FilingIndex
← The Wire
LXEONasdaq

Lexeo Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · CIK 1907108

Develops gene therapies for genetic cardiovascular diseases using AAV vectors

red 8-K · 90d
$343M
Market cap
$4.81
Last close
+1.3%
1D
-4.6%
5D
1.0M
Volume
Price · last 39 sessions-17.1%
May 4L $4.13 · H $6.23Jun 29
70
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end

Insider Activity

In the 90 days to Feb 18, 2026: 2 sold $84K.

DateInsiderActionSharesPriceValue
Feb 18, 2026Townsend Richard NolanChief Executive OfficerSell10,173$6.38$65K
Feb 18, 2026Otero Jose ManuelChief Operating OfficerSell3,016$6.40$19K
Nov 18, 2025Townsend Richard NolanChief Executive OfficerSell1,127$9.27$10K
Nov 18, 2025Otero Jose ManuelChief Operating OfficerSell721$9.27$7K
Nov 18, 2025Adler EricChief Medical OfficerSell615$9.27$6K
Nov 18, 2025Robertson JennyChief Legal OfficerSell549$9.27$5K
Nov 18, 2025See Tai SandiChief Development OfficerSell386$9.27$4K
Oct 17, 2025Townsend Richard NolanChief Executive OfficerSell12,985$8.94$116K
Oct 17, 2025See Tai SandiChief Development OfficerSell3,844$8.94$34K
Oct 17, 2025Robertson JennyChief Legal OfficerSell3,486$8.94$31K
Oct 17, 2025Adler EricChief Medical OfficerSell3,344$8.94$30K
Oct 17, 2025Otero Jose ManuelChief Technical OfficerSell2,091$8.94$19K
Oct 17, 2025Townsend Richard NolanChief Executive OfficerSell148$9.56$1K
Oct 17, 2025See Tai SandiChief Development OfficerSell44$9.56$421
Oct 17, 2025Robertson JennyChief Legal OfficerSell40$9.56$382
Oct 17, 2025Adler EricChief Medical OfficerSell38$9.56$363
Oct 17, 2025Otero Jose ManuelChief Technical OfficerSell24$9.56$229
Aug 18, 2025Otero Jose ManuelChief Technical OfficerSell721$9.27$7K

Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.

Similar companies

Comparable business profile · signals at a glance